Novo Nordisk follows Eli Lilly on insulin price cuts
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Drugs
Pharma
Drugs
Pharma
Diabetes, obesity drugs boost Novo Nordisk profit, sales
Novo Nordisk net profit rose 14% year-on-year in nine months to September as it forecasted higher profit and sales for the year on.